# Madrigal Pharmaceuticals, Inc. (MDGL) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$300M |
| 2024 | -$498M |
| 2023 | -$380M |
| 2022 | -$294M |
| 2021 | -$242M |
| 2020 | -$207M |
| 2019 | -$95M |
| 2018 | -$41M |
| 2017 | -$32M |
| 2012 | -$61M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$93M |
| 2025-09-30 | -$114M |
| 2025-06-30 | -$47M |
| 2025-03-31 | -$79M |
| 2024-09-30 | -$116M |
| 2024-06-30 | -$163M |
| 2024-03-31 | -$152M |
| 2023-09-30 | -$99M |
| 2023-06-30 | -$86M |
| 2023-03-31 | -$78M |
| 2022-03-31 | -$58M |
| 2021-09-30 | -$63M |
| 2021-06-30 | -$62M |
| 2021-03-31 | -$53M |
| 2020-09-30 | -$59M |
| 2020-06-30 | -$50M |
| 2020-03-31 | -$38M |
| 2019-09-30 | -$24M |
| 2019-06-30 | -$23M |
| 2019-03-31 | -$18M |
| 2018-03-31 | -$7M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/MDGL/operating-income)